Moreover, a high expression of NUCB2/nesfatin‐1 in GC tissues is significantly associated with tumour depth, lymph node metastasis, lymphatic invasion, venous invasion and clinical stage.15 This evidence concerns the gene NUCB2 and neoplasm.